Alfasigma USA Revenue and Competitors

Claim your profile

Covington, LA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Alfasigma USA's estimated annual revenue is currently $47.2M per year.(i)
  • Alfasigma USA's estimated revenue per employee is $201,000

Employee Data

  • Alfasigma USA has 235 Employees.(i)
  • Alfasigma USA grew their employee count by 26% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.3M138%$28.7MN/A
#2
$2.2M2713%N/AN/A
#3
$3.3M403%N/AN/A
#4
$3.4M4117%N/AN/A
#5
$6.9M8334%N/AN/A
#6
$128M5515%N/AN/A
#7
$3.5M425%N/AN/A
#8
$0.8M4N/AN/AN/A
#9
$34.4M17126%N/AN/A
#10
$3.7M457%N/AN/A

Pamlab, formerly part of Nestle Health Sciences, is now Alfasigma USA. Alfasigma USA, Inc. distributes a portfolio of prescription nutritional products to help individuals who are suffering from GI disorders (VSL#3®), major depressive disorder (Deplin®), diabetic peripheral neuropathy (Metanx®), and mild cognitive impairment (CerefolinNAC®). Through the company's commitment to improving patients health and quality of life, Alfasigma USA, Inc. strives to provide innovative solutions that respond to the needs of a changing society. Alfasigma USA has corporate headquarters in Covington, LA and a newly opened commercial hub in Bedminster, NJ. Discover Alfasigma USA at http://www.alfasigmausa.com.

keywords:N/A

N/A

Total Funding

235

Number of Employees

$47.2M

Revenue (est)

26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Alfasigma USA News

2022-04-06 - Medical Foods Market 2022 Analysis by Key Players, Trends, Demand, Products and Suppliers Forecast to 2026

Alfasigma USA, Inc. ... The U.S. is a frontrunner in the medical foods industry, ... 7th Floor, New York City, NY 10007 United States

2022-04-06 - The next 10 years to witness a digitally topsy-turvy scenario in ...

Alfasigma USA, Inc. ... The U.S. is a frontrunner in the medical foods industry, ... 7th Floor, New York City, NY 10007 United States

2019-09-08 - Alfasigma brings Zelnorm back to US market

The US subsidiary of Italian drugmaker Alfasigma yesterday announced that Zelnorm (tegaserod) is now available in the USA as a prescription ...

2019-09-03 - Global Irritable Bowel Syndrome (IBS) Market Size 2019 ...

... market are Allergan Plc (Ireland), Sucampo Pharmaceuticals (U.S.), ... Sebela Pharmaceuticals (Ireland), Probi (Sweden), Alfasigma USA, ...

2019-09-03 - Alfasigma USA Announces ZELNORM™ (tegaserod) Now ...

Alfasigma USA, Inc. today announced that ZELNORM™ (tegaserod) is now available in the United States as a prescription pharmaceutical ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$71M239-1%N/A
#2
$60.9M2445%N/A
#3
$56.2M2546%N/A
#4
$50.3M254-5%N/A
#5
$109M318-5%$20M